MSD (Japan) Co., Ltd. · 66-66 · JAPAN
For MSD (Japan) Co., Ltd., import alert is 66-66; country is JAPAN; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product is Levadopa; product code is 62 J - S 09 Levodopa (Anti-Parkinsonian), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is Kowa Bldg.No.16 Annex, 9-20 , Tokyo, JAPAN, verified against its source on 2026-09-30.
- Firm
- MSD (Japan) Co., Ltd. verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- JAPAN verified
- Address
- Kowa Bldg.No.16 Annex, 9-20 , Tokyo, JAPAN verified
- Date published
- 09/30/2009 verified
- Product code
- 62 J - S 09 Levodopa (Anti-Parkinsonian), Active Pharm Ingred/Chems for Further Manuf verified
- Product
- Levadopa verified
- FDA notes
- 11/2/2000 verified
What the source says
MSD (Japan) Co., Ltd. Date Published : 09/30/2009 Kowa Bldg.No.16 Annex, 9-20 , Tokyo, JAPAN
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
62 J - S 09 Levodopa (Anti-Parkinsonian), Active Pharm Ingred/Chems for Further Manuf Date Published: 04/01/2019 Desc: Levadopa Notes: 11/2/2000
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.